| Date |
Event
|
Comment |
|
23.2.2011-24-2-2011 |
Antibody Engineering & Design, Frankfurt
|
Poster
|
23.2.2011-25.2.2011
|
Molecular Medicine Tri-Conference
|
Poster
Kl-bodies: a novel fully human bispecific IgG format
|
28.2.2011-2.3.2011
|
Cell Culture World Congress, Munich
|
Presentation
|
14.3.2011-16.3.2011
|
BioEurope Spring, Milano
|
Partnering, one-on-one
|
9.5.2011-13.5.2011
|
7th Annual PEGS Summit, Boston
|
Two oral presentations:
- Deep Sequencing of Captured CDRH3 Repertoires for Accelerated Antibody Discovery, Nicolas Fischer,
Using a natural or synthetic CDR3 capture approach, multiple scFv
libraries were generated. Deep sequencing of the initial diversity and
after each selection round provided insights into sequence evolution
against different targets. The resulting extensive sequence information
and clone enrichment profiles allow for library quality assessment and
by-passing primary screening thus accelerating antibody discovery.
- Pan-Specific Antibodies Targeting Redundant Signaling Pathways in Autoimmunity, Marie Kosco-Vilbois.
In certain diseases, targeting a single protein might not be
sufficient to achieve efficacy and this has prompted the development of
innovative formats that allow for multiple targeting. We describe the
isolation and engineering of antibodies that are selectively
cross-reactive and neutralize more than one target thus leading to
improved neutralization of redundant signaling pathways.
|
| 23-24.5.2011 |
BioEquity Europe, Paris
|
Company presentation
|
27-28.5.2011
|
EULAR 2011, London
|
Oral presentation:
The potential of an anti-CD3 therapy in theumatoid arthritis: mechanism of action and synergy with additional therapies
Poster presentation:
NI-1201, the development of a novel, high affinity, fully human
monoclonal antibody directed against the interleukin-6 (IL-6) signalling
pathway
|
| 27-28.9.2011 |
World Bispecific Antibody Summit, Boston
|
Oral presentation
|
9-11.10.2011
|
BioPartnering London
|
Partnering, one.on-one and presentation
|
| 11.12.10.2011 |
GTC - Protein Discovery & Therapeutics Conference, San Diego
|
Oral presentation (bispecific mAb format)
|
| 19-20.10.2011 |
Bioproduction, Berlin
|
Oral presentation (bispecific mAb format)
|
| 19-21.10.2011 |
PEGS Europe, Hannover
|
Oral presentation (bispecific mAb format)
Poster (panspecific format mAbs)
|
| 31.10-4.11.2011 |
BPI |
Oral presentation (bispecific mAb format)
|
| 31.10-2.11.2011 |
BioEurope, Düsseldorf
|
Partnering, One-on-one
|
| 4-7.11.2011 |
ACR/ARHP Annual Scientific Meeting, to be held in Chicago, IL |
Poster presentations:
- Session: T-cell Biology and Targets in Autoimmune Disease: Lymphocyte Biology and Targets in Autoimmune Disease
"Short combination therapy with anti-CD3 and anti-TNF is associated with long term inhibition of established collagen-induced arthritis"
Time: Tuesday, November 8, 2011, 9:00 AM - 6:00 PM
Location: McCormick Place Convention Center: Poster Hall
Presentation Number: 2336
- Session: Innate Immunity and Rheumatic Disease
"NI-0101, a therapeutic TLR4 monoclonal antibody for rheumatoid arthritis"
Time: Monday, November 7, 2011, 9:00 AM - 6:00 PM
Location: McCormick Place Convention Center: Poster Hall Presentation Number: 977
- Session: Cytokines, Mediators, and Gene Regulation
"Preferential Inhibition of IL-6 TRANS-Signaling Shows Potent Anti-Inflammatory Activity In Vivo: The Potential of NI-1201, a Novel Fully Human IL-6R Monoclonal Antibody"
Time: Sunday, November 6, 2011, 9:00 AM - 6:00 PM
Location: McCormick Place Convention Center: Poster Hall Presentation Number: 63
|
| 16-17.11.2011 |
Targeted Antibodies for Cancer, London
|
|
| 4-8.12.2011 |
Antibody Engineering, San Diego
|
Sponsored workshop
|
| 11-12.1.2012 |
PepTalk, San Diego
|
Oral presentation (bispecific mAb format)
|
| 17-19.1.2012 |
Visiongain- Recombinant Antibody Conference
|
Oral presentation (bispecific mAb format and Deep Sequencing)
|
| 26-28.3.2012 |
4th International Congress of Antibodies
|
Oral presentation (bispecific mAb format)
|
